Dexcom’s Stelo glucose biosensor is promoted as a continuous monitor that helps track glucose in the body. What separates it from other continuous glucose monitoring (CGM) systems — special ...

Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs.

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support ...

and now is creating a new category by bringing the first glucose biosensor cleared for use over-the-counter,” said Jake Leach, the company’s chief operating officer. “Based on our experience ...

近日，专注于外科和医疗器械及设备的智能生物解决方案公司 (Intelligent Bio Solutions Inc.) (NASDAQ:INBS)宣布增加其流通股总数。截至2025年1月2日收盘，该公司报告普通股总数为4,807,068股。

Researchers from Binghamton University are developing a paper-based biosensor that promises pain-free diabetes monitoring ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

Thankfully, in March 2024, the FDA cleared Dexcom to market and granted it the legal power to sell the Stelo Glucose Biosensor System directly to consumers. It's indicated for diabetics not ...

SD Bio retrieves investment from UXN as shareholder stakes decrease SD Bios partial redemption leads to bumps in UXNs funding ...

Stelo, the first over-the-counter glucose biosensor cleared by the Food and Drug Administration, is the first Dexcom product to use GenAI-enabled technology to produce weekly insights.

Forget going to the doctor’s office; these companies are putting the power of tracking every aspect of your health into our ...